Search - tctmd.com

Displaying 121 - 132 of 132

Sort: Relevancy | Date

News Conference News TCT 2012

Second-Generation DES Safer, More Effective Than BMS in STEMI at 1 Year

October 31, 2012

News Daily News

Korean Registry Confirms Edge of Everolimus- Over Zotarolimus-Eluting Stents

September 19, 2012

News Daily News

Meta-Analysis: First-Gen DES Show Long-term Safety, Efficacy in STEMI Setting

L.A. McKeown

April 25, 2012

Presentation TCT 2012

Frequency and Predictors of Drug Eluting Stents Implantation in Patients with Acute Myocardial Infarction - Analysis from the PL-ACS Registry.

Presenter: Marek Gierlotka, Mariusz Gasior, Michal Hawranek, Zbigniew Kalarus, Pawel Buszman, Jacek Legutko, Andrzej Lekston, Lech Polonski

January 03, 2012

News Daily News

FFR-Guidance Demonstrates Benefits in Patients with Unstable Angina, NSTEMI

L.A. McKeown

December 08, 2011

News Conference News

ISAR-REACT 4: Bivalirudin Reduces Major Bleeding in NSTEMI Patients

November 13, 2011

News Daily News

Bivalirudin Decreases Bleeding Regardless of Heparin Anticoagulation Level

Yael L. Maxwell

October 13, 2011

News Daily News

Study Proposes New CK-MB Threshold for Periprocedural MI

Caitlin E. Cox

October 12, 2011

News Conference News

Two Trials Show Favorable Results with XIENCE V vs. Earlier DES, BMS

September 02, 2011

News Daily News

HORIZONS-AMI Published: Bivalirudin, Taxus Stay Strong at 3 Years

Jason Kahn

June 13, 2011

News Daily News

DES Linked with More Stent Thrombosis Than BMS 1 Year After Primary PCI

January 18, 2011

News Daily News

Higher Long-term Mortality for Women Undergoing Primary PCI

Leah Lawrence

January 10, 2011

Advertisement

Second-Generation DES Safer, More Effective Than BMS in STEMI at 1 Year

Korean Registry Confirms Edge of Everolimus- Over Zotarolimus-Eluting Stents

Meta-Analysis: First-Gen DES Show Long-term Safety, Efficacy in STEMI Setting

Frequency and Predictors of Drug Eluting Stents Implantation in Patients with Acute Myocardial Infarction - Analysis from the PL-ACS Registry.

FFR-Guidance Demonstrates Benefits in Patients with Unstable Angina, NSTEMI

ISAR-REACT 4: Bivalirudin Reduces Major Bleeding in NSTEMI Patients

Bivalirudin Decreases Bleeding Regardless of Heparin Anticoagulation Level

Study Proposes New CK-MB Threshold for Periprocedural MI

Two Trials Show Favorable Results with XIENCE V vs. Earlier DES, BMS

HORIZONS-AMI Published: Bivalirudin, Taxus Stay Strong at 3 Years

DES Linked with More Stent Thrombosis Than BMS 1 Year After Primary PCI

Higher Long-term Mortality for Women Undergoing Primary PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content